Cano-Mejia et al. showed photothermal immunotherapy, which combines PB nanoparticle (PBNP)-based PTT with anti-CTLA-4 checkpoint inhibition for treating neuroblastoma. The gene discussed is CTLA4; the disease is neuroblastoma.